Who is Medibio?
We are a health technology company pioneering the use of objective measures to aid in the early detection and screening of mental health conditions. Through our Corporate Health product, the Company offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company was founded in Australia, with offices located in Perth (WA), Melbourne (VIC) and U.S. offices in Minneapolis, MN. Medibio is listed on the Australian Securities Exchange Ltd and trades on the OTCQB Venture Market. Investors can find additional information on www.otcmarkets.com and www.asx.com.au.
The company’s focus is based on benchmark research linking circadian heart rate and mental health. Today, we use diverse data sets to identify the link between physiologic measures and mental health.
Our solutions are designed to capture and process biometric features associated with circadian heart rate to create an objective view of mental health. Our proprietary data processing and algorithms correlate these features with specific mental health conditions. By improving upon self-reported assessments, our technology empowers clinicians to aid in early detection of mental health conditions and empowers individuals to screen and better understand their mental wellness.